# iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions

> **NCT02552537** · PHASE4 · COMPLETED · sponsor: **University of Zurich** · enrollment: 44 (actual)

## Conditions studied

- Food Allergy

## Interventions

- **DRUG:** Omeprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02552537
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2017-05-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02552537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02552537, "iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02552537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*